DrugPatentWatch Database Preview
Boscogen Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for BOSCOGEN, and what generic and branded alternatives to BOSCOGEN drugs are available?
BOSCOGEN has five approved drugs.
Summary for Boscogen
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Boscogen
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boscogen | CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | TABLET;ORAL | 040644-001 | May 30, 2006 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Boscogen | REPAGLINIDE | repaglinide | TABLET;ORAL | 091517-001 | Apr 24, 2015 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Boscogen | ARIPIPRAZOLE | aripiprazole | TABLET;ORAL | 091279-004 | Jan 9, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Boscogen | REPAGLINIDE | repaglinide | TABLET;ORAL | 091517-002 | Apr 24, 2015 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
